Abstract:Background and objectives: Most individuals with spinal muscular atrophy (SMA) on disease-modifying therapies continue to have chronic motor impairment. Insights into brain involvement in SMA may open new pathways for adjunctive therapies to optimize outcomes. We aimed to characterize macrostructural brain abnormalities detected by MRI in individuals with SMA compared with peer controls. Methods: We conducted a cross-sectional case-control study of children and adults with a confirmed genetic diagnosis of 5q SMA, and peer controls matched by age and sex. Brain MRIs acquired on a 3T MRI scanner through a standardized research protocol were reviewed to qualitatively assess the presence of macrostructural changes. The primary outcome was the presence of any structural brain anomaly on MRI. In addition, the total volume of each participant's lateral ventricles was quantified by volumetry using MRIcron. Genetic and clinical variables, including SMN2 copy number and motor function (Hammersmith Functional Motor Scale Expanded and Revised Upper Limb Module scores), were then correlated with neuroimaging findings. Results: A total of 42 participants completed the study (mean age 17.4, range 7-40; 67% male). Of the 21 individuals with 5q SMA, 9 (43%) had macrostructural brain abnormalities identified on MRI compared with 2 of 21 (10%) peer controls (odds ratio 7.1, 95% confidence interval 1.4-34.0). In patients with SMA, the most common structural changes were widening of the arachnoid spaces (n = 4) and ventriculomegaly (n = 4). Individuals with SMA had larger median lateral ventricular volume than their normally developing peers (9.3 mL, interquartile range [IQR] 5.5-13.1 vs 5.3 mL, IQR 3.8-9.8; p = 0.034). Structural brain abnormalities were more frequent in those with 2 SMN2 copies (3/5, 60%) compared with 3 or 4 SMN2 copies (4/10, 40% and 2/6, 33% respectively), not reaching significance. We found no association between structural changes and motor function scores. Discussion: Individuals with SMA have higher rates of macrostructural brain abnormalities than their neurotypical peers, suggesting CNS involvement in SMA. Understanding changes in the brain architecture of the SMA population can inform the development of adjunct therapies targeting the CNS and potentially guide rehabilitation strategies.

The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy

Nutritional, Lipid Metabolic and Body Composition Features of Children with Spinal Muscular Atrophy

Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy

Unveiling the connection between gut microbiome and metabolic health in individuals with chronic spinal cord injury

Glucose and Lipid Metabolism Disorders in Adults with Spinal Muscular Atrophy Type 3

Mitochondrial Dysfunction in Spinal Muscular Atrophy

Exploring the Gut Microbiota–Muscle Axis in Duchenne Muscular Dystrophy

Macrostructural Brain Abnormalities in Spinal Muscular Atrophy: A Case-Control Study

Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease

[Molecular pathological mechanism of liver metabolic disorder in mice with severe spinal muscular atrophy]

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy

Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses.

Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy

Alterations of the duodenal mucosal microbiome in patients with metabolic dysfunction-associated steatotic liver disease

Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice.

Pre-natal manifestation of systemic developmental abnormalities in spinal muscular atrophy

Gut Microbiota Alterations in Adolescent Idiopathic Scoliosis: a Comparison Study with Healthy Control and Congenital Scoliosis

Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy